肺炎/中西医结合疗法

肺炎/中西医结合疗法的相关文献在2000年到2019年内共计58篇,主要集中在内科学、中国医学、儿科学 等领域,其中期刊论文58篇、专利文献68928篇;相关期刊7种,包括陕西中医、中国中医药科技、中医研究等; 肺炎/中西医结合疗法的相关文献由136位作者贡献,包括乔健、于红权、付相建等。

肺炎/中西医结合疗法—发文量

期刊论文>

论文:58 占比:0.08%

专利文献>

论文:68928 占比:99.92%

总计:68986篇

肺炎/中西医结合疗法—发文趋势图

肺炎/中西医结合疗法

-研究学者

  • 乔健
  • 于红权
  • 付相建
  • 任根魁
  • 何苡
  • 余胜珠
  • 余蕊
  • 佟丹
  • 侯小霞
  • 兰伯恩
  • 期刊论文
  • 专利文献

搜索

排序:

学科

年份

    • 罗峰; 杨曼
    • 摘要: 目的:观察清瘟败毒饮合大承气汤联合西药治疗肺炎合并脓毒症的临床疗效.方法:将78肺炎合并脓毒症患者采用随机数字表法随机分为治疗组和对照组.对照组给予常规西药治疗,治疗组在对照组治疗基础上加服清瘟败毒饮合大承气汤(生石膏、生地黄、知母、玄参、牡丹皮、黄芩、桔梗、大黄、生甘草、枳实、浙贝母、厚朴、炒杏仁、川贝母、芒硝)治疗,1剂/d,早晚口服,病情严重者可鼻饲.两组均以7 d为1个疗程,连续治疗2个疗程.结果:治疗组痊愈20例,显效11例,有效16例,无效2例,有效率为94.87%;对照组痊愈12例,显效10例,有效18例,无效9例,有效率为76.92%.两组对比,差别有统计学意义(P<0.05).治疗后,治疗组APACHE-II评分较对照组降低(P<0.05).结论:在肺炎合并脓毒症治疗中,清瘟败毒饮合大承气汤联合西药利于患者病情恢复,改善其健康状况,且安全性较高,值得借鉴.
    • 于红权
    • 摘要: 目的:分析麻杏石甘汤对肺炎血清炎症因子影响、免疫球蛋白水平变化及临床治疗效果.方法:本研究对象选取118例支原体肺炎患儿,按照随机数字表法分成对照组和观察组各59例.对照组患儿给予抗感染、退热等常规治疗,观察组患儿在此基础上辅以麻杏石甘汤治疗.连续治疗5d,对比两组治疗效果、血清炎症因子水平、免疫球蛋白水平、不良反应发生率的差异.结果:治疗后观察组愈显率为96.61%,明显高于对照组的84.75%(P< 0.05).治疗后观察组血清CRP、TNF-α、IL-6水平低于对照组,组间有显著的统计学差异(P<0.05).治疗后观察组IgG、IgM、IgA水平高于对照组(P<0.05).治疗期间观察组不良反应发生率为5.08%,低于对照组的18.64%(P<0.05).结论:采用麻杏石甘汤治疗小儿肺炎的疗效确切,有助于减轻机体炎症反应程度、增强免疫功能,同时降低不良反应风险.%Objective:To analyze the effect of Maxing Shigan decoction on serum inflammatory factors,Gansu pneumonia changes in immunoglobulin levels and clinical therapeutic effect.Methods:118 children with mycoplasma pneu-monia were selected and divided into control group and observation group according to random number table,59 cases in each group.The control group were given routine treatment of anti infection,such as fever,the patients in the observation group on the basis of combined Maxing Shigan decoction in the treatment.Continuous treatment of 5d,compared two groups of treatment effect,serum inflammatory factors levels,immunoglobulin levels,adverse reaction rate differences. Results:After treatment,the markedly effective rate of the observation group was 96.61%,which was significantly higher than that of the control group 84.75%,and there was a significant difference between the two groups(P< 0.05).After treatment,serum CRP,TNF-a,IL-6 level lower than the control group,there was a significant difference between the groups(P<0.05).After treatment,the observation group IgG,IgM,IgA levels higher than the control group,there was a significant difference between the groups(P<0.05).During the treatment,the incidence of adverse reactions in the ob-servation group was 5.08%,significantly lower than 18.64% in the control group,there was a statistically significant difference between the two groups(P<0.05).Conclusion:The curative effect of Maxing shigan decoction in the treatment of infantile pneumonia,help to reduce inflammation,enhance immune function,and reduce the risk of adverse reactions.
    • 贺孝良; 侯小霞
    • 摘要: Objective:To study the clinical efficacy and safety of glucocorticoid combined with Xiao'er Feike granule in the treatment of pneumonia in children.Methods:112 cases of children with pneumonia was studied, which were randomly divided into experimental group and control group(n=56),control group used glucocorticoid treatment,experimental group gave Xiao'er Feike granule treatment on the basis of the control group,treatment for 2 weeks,the clinical curative effect,the children with pulmonary function(FEV1/FVC,PEF and MBC),inflammatory markers(IL-2,IL-6)and adverse reactions of 2 group were observed.Results:the total effective rate of the experi-mental group(96.4%)was significantly higher than the control group(78.6%),with statistical significance(P<0.05);FEV1/FVC,PEF and MBC of experimental group were significantly higher than the control group,with sta-tistical significance(P< 0.05);IL-2,IL-6 of experimental group was significantly lower than that of control group, with statistical significance(P< 0.05);2 groups had no nausea,headache,drowsiness,dry mouth,mild stuffy nose, chest tightness,heart palpitations,tremor,adverse reactions such as anaphylactic shock drugs.Conclusion:glucocor-ticoid combined with Xiao'er Feike granule in the treatment of children pneumonia in order to effectively improve the patient's lung function and ease the inflammatory response,safe and reliable%目的:探讨糖皮质激素结合小儿肺咳颗粒治疗儿童肺炎的临床疗效及安全性.方法:选取112例儿童肺炎进行研究,随机分为治疗组和对照组各56例,对照组采用糖皮质激素治疗,治疗组在对照组的基础上进行小儿肺咳颗粒治疗,治疗两周时间,观察两组患儿的临床疗效、肺功能(FEV1/FVC、PEF和MBC)、炎性指标(IL-2、IL-6)及不良反应.结果:治疗组的总有效率(96. 4%)明显高于对照组(78.6%),差异具有统计学意义(P<0.05);治疗组的 FEV1/FVC、PEF 和M BC明显高于对照组,差异具有统计学意义(P<0.05);治疗组的IL-2、IL-6水平明显低于对照组,具有统计学意义(P<0.05);两组患儿均无恶心、头疼、口干、嗜睡、鼻塞、轻度胸闷、心悸、手抖、过敏性休克等药物不良反应.结论:糖皮质激素结合小儿肺咳颗粒治疗儿童肺炎可以有效改善患者的肺功能,缓解炎性反应,安全可靠.
    • 方柯南
    • 摘要: 目的:探讨参麦注射液联合利奈唑胺治疗儿童重症肺炎临床疗效及对炎性因子的影响.方法:收集100例儿童重症肺炎患者为研究对象,按照随机数字表法分为观察组和对照组,每组各50例.对照组给予利奈唑胺治疗,观察组在对照组基础上增加参麦注射液治疗,两组患者均连续治疗14d.治疗结束后比较两组患者临床效果以及不良反应发生情况.比较分析治疗前后两组患者血清炎性因子(IL-6、IL-8、CRP、TNF-α)水平变化情况.结果:观察组总有效率为92%,对照组为72%,两组比较具有统计学差异(P0.05),治疗后两组患者IL-6、IL-8、CRP以及TNF-α水平显著下降(P<0.05),且观察组IL-6、IL-8、CRP以及TNF-α水平均显著低于对照组(P<0.05).观察组不良反应发生率为10%,显著低于对照组的28%.结论:参麦注射液联合利奈唑胺治疗儿童重症肺炎临床效果较好,症状改善明显,不良反应发生率低,并减轻患儿炎症反应,有利于患儿的恢复.
    • 罗杨敏; 孙维旭; 王银菊; 杨秀青; 郭利娟
    • 摘要: Objective :To investigate the effect of Liujunzi decoction combined with western medicine on chronic pul-monary infection and its influence on lung function .Methods :82 patients with chronic pulmonary infection admitted as the research subjects .They were divided into control group and observation group by random number table grouping method , 41 cases in each group .All patients were given oxygen inhalation ,expectorant ,cough ,correction of bronchiectasis ,mainte-nance of water and electrolyte and acid-base balance and other symptomatic treatment .The control group selected appropri-ate antibiotics for anti infection treatment according to the results of sputum culture .The observation group was treated with Liujunzi decoction on the basis of the control group .The improvement of lung function and pulmonary infection and its clinical effect were compared between the two groups before and after 3 courses of treatment .Results :After 1 ,2 ,and 3 months of treatment ,the scores of TCM symptoms in the two groups decreased significantly ,and the observation group de-creased more significantly than the control group (P< 0 .05).There was no significant difference in FVC ,FEV1 and FEV1% before treatment in the two groups (P>0 .05) ,and the levels of FVC ,FEV1 and FEV1% in the two groups were significantly higher (P<0 .05) after treatment ,and the levels of FVC ,FEV1 and FEV1% in the observation group were higher than those of the control group (P<0.05) ,and the two groups were significantly decreased after treatment .And the observation group was more obvious than the control group (P<0 .05).There was no significant difference between the two groups before the treatment of CD3+ T ,CD4+ T ,CD8+ T and CD4+ T/CD8+ T (P>0.05) ,and there was no significant change in the level of CD3+ T in the two groups (P>0.05).The average level of CD4+ T and CD4+ T/CD8+ T water was significantly higher .It was significantly higher than that in the control group (P<0 .05) ,and the level of CD8+ T was sig-nificantly lower than that in the control group (P<0 .05).The quality of life scores of the two groups increased significantly after treatment ,and the difference was statistically significant (P<0.05).Follow up for 12 months ,there was no signifi-cant difference in recurrence rate between the two groups (P>0.05).Conclusion :Liujunzi decoction combined with west-ern medicine can significantly improve the pulmonary function and pulmonary infection in patients with chronic pulmonary infection.It is effective in clinical treatment and can be used in the clinical treatment of chronic pulmonary infection .%目的:探讨六君子汤联合西药治疗慢性肺炎的疗效及对患者肺功能的影响.方法:选择慢性肺炎患者82例为研究对象.采用随机数字表分组法将其分为对照组和观察组,各41例.所有患者均给予吸氧、祛痰、止咳、纠正支气管扩张、维持水电解质以及酸碱度平衡等相关对症治疗.对照组根据痰培养结果选择合适的抗生素进行抗感染治疗,观察组在对照组基础上给予六君子汤治疗,比较两组治疗前、治疗3个疗程后肺功能、肺炎改善情况及其临床疗效.结果:治疗后1 、2 、3个月,两组患者中医症状积分均明显下降,且观察组比对照组下降更明显(P<0.05).两组治疗前FVC 、FEV1 、FEV1% 比较差异均无统计学意义(P>0.05) ;两组治疗后FVC 、FEV1 、FEV1% 水平均显著升高(P<0.05) ;观察组治疗后FVC 、FEV1 、FEV1% 水平均高于对照组(P<0.05) ;两组治疗后WBC 、CRP 、肺炎指数和APACHEII评分均明显下降,且观察组比对照组更明显(P<0.05).两组治疗前CD3+ T 、CD4+ T 、CD8+ T及CD4+ T/CD8+ T比较差异无统计学意义(P>0.05) ;两组治疗后CD3+ T水平均无明显变化( P>0.05) ,CD4+ T及CD4+ T/CD8+ T水平均显著升高( P<0 .05 ) ,CD8+ T水平显著降低(P<0.05) ;观察组治疗后CD4+ T及CD4+ T/CD8+ T水平明显高于对照组( P<0.05) ,CD8+ T水平明显低于对照组(P<0.05).两组治疗后生活质量评分显著升高,与治疗前比较差异有统计学意义(P<0.05).随访12个月,两组复发率比较差异无统计学意义(P>0.05).结论:六君子汤联合西医治疗可显著改善慢性肺炎患者肺功能及肺炎情况,临床疗效确切.
    • 张峥嵘; 邢刚; 赵园珠
    • 摘要: 目的:研究小儿肺炎支原体感染中医辨证治疗临床效果.方法:将126例小儿肺炎支原体感染患儿依据就诊时间随机分为对照组和治疗组各63例.对照组患儿采用镇咳等西医对症治疗,观察组患儿在对症治疗的基础上采用善散汤加减治疗.连续治疗2个疗程(7d为1疗程)后,观察对比两组患儿临床治疗效果.结果:治疗组患儿总有效率明显高于对照组,差异有统计学意义(P<0.05);治疗组患儿咳嗽、发热、咳痰消失时间明显短于对照组,差异有统计学意义(P<0. 05);治疗组患儿肺炎支原体抗体IgM 转阴率明显优于对照组,差异有统计学意义(P<0.05);治疗后两组患儿白细胞(WBC)、C反应原蛋白(CRP)明显降低,且治疗组WBC、CRP明显低于对照组,差异有统计学意义(P<0.05);治疗组患儿不良反应发生率、复发率明显低于对照组,差异有统计学意义(P<0.05).结论:中医辨证治疗小儿肺炎支原体感染临床疗效显著,无明显不良反应,可有效避免耐药性,值得临床应用.
    • 白涛敏; 达春水
    • 摘要: Objective:To explore the clinical effect of Xiyanping injection in the treatment of infantile viral pneumonia.Methods:123 patients with infantile viral pneumonia were selected.They were divided into the observa-tion group(62 patients)and the control group(61 patients).The observation group were given Xiyanping injection. The control group was treated with ribavirin injection.We compared the therapeutic effect of two groups.Results:In the observation group,the temperature reduction time(2.03 ± 0.21)d,cough expectoration disappearance time(4.58 ± 0.42)d,were shorter than those in the control group(the temperature reduction time(2.49 ± 0.32)d,cough expec-toration disappearance time(5.82 ± 0.39)d),with significant difference(P<0.001).The total effective rate of ob-servation group was 93.55% was significantly higher than 80.33% of the control group;with significant difference (P<0.05).Conclusion:The clinical effect of Xiyanping injection in the treatment of infantile viral pneumonia was significant,with few adverse reactions.It is effective.It is worthy of clinical application.%目的:观察喜炎平注射液治疗小儿病毒性肺炎的临床疗效.方法:选取病毒性肺炎患儿123例,随机分为观察组与对照组,其中观察组62例,对照组61例.观察组患儿给予喜炎平注射液静脉滴注治疗,对照组患儿给予利巴韦林注射液静脉滴注治疗,比较两组的临床效果.结果:观察组患儿治疗后退热时间(2.03 ± 0.21)d、咳嗽、咳痰消失时间(4.58 ± 0.42)d均明显短于对照组的退热时间(2.49 ± 0.32)d、咳嗽、咳痰消失时间(5.82 ± 0.39)d,两组结果比较差异具有统计学意义(P<0.001).观察组总有效率93.55%;对照组总有效率80.33%.观察组总有效率明显高于对照组,两组比较差异具有统计学意义(P<0.05).结论:喜炎平注射液用于治疗病毒性肺炎患儿的临床效果显著,不良反应少见,可作为治疗小儿病毒性肺炎的有效措施,值得临床应用.
    • 王彦平; 高貂艳; 郝巧茸
    • 摘要: 目的:观察中药灌肠助治小儿肺炎(痰热闭肺型)的疗效.方法:对照组给予常规西医治疗及对症治疗,治疗组在西医治疗的基础上联合中药灌肠.结果:治疗组治愈27例,好转3例,住院平均时间8.96 d;对照组治愈23例,好转7例,住院平均时间11.85 d.治疗组治的愈率为90.00%(27/30),对照组76.00%(23/30).结论:中药灌肠助治小儿肺炎疗效值得肯定.
    • 官江
    • 摘要: 目的 探讨中西医结合治疗重症肺炎致呼吸衰竭的可行性及有效性.方法 选择2014年6月至2015年6月该院诊断为重症肺炎出现呼吸衰竭的86例患者作为研究对象,采用双盲法将其随机分为西药组和中西医结合组,每组43例.西药组给予西药治疗,中西医结合组在此基础上加用中药制剂,对给药前后患者血气指标、肺部通气情况进行观察,并对疾病治疗效果进行评估.结果 中西医结合组治疗后患者呼吸衰竭改善总有效率为97.7%(42/43),明显高于西药组86.0%(37/43),差异有统计学意义(P<0.05).治疗后两组呼吸、心率、血气指标均较治疗前有所改善,且中西医结合组呼吸功能、二氧化碳分压(PaCO2)、氧分压(PaO2)指标恢复效果均优于西药组,差异均有统计学意义(P<0.05).结论 临床上对于重症肺炎出现呼吸衰竭者,使用中西医结合进行治疗,患者症状改善良好、恢复快,值得临床推广.
    • 安亚东
    • 摘要: 目的:研究千金苇茎汤合桃仁红花煎加减化裁对呼吸机相关性肺炎的治疗效果,为临床治疗提供指导意义。方法:选自我院2012年5月至2013年5月呼吸科收治的57例因使用呼吸机所致的相关性肺炎患者,将其随机分为两组,其中对照组29例,采用亚胺培南500mg 加西司他丁500mg ,每日3次,静滴治疗。治疗组28例,在对照组治疗的基础上加用千金苇茎汤合桃仁红花煎治疗,每日1剂,水煎分早晚服用。以7d 为1个疗程,对比观察两组患者肺部炎症的缓解改善情况,分析千金苇茎汤合桃仁红花煎的治疗效果。结果:治疗组在1个疗程后胸部 CT 炎症吸收范围及血气分析指标明显优于对照组(P<0.05),差异有统计学意义。结论:千金苇茎汤合桃仁红花煎对治疗呼吸机相关性肺炎的临床疗效显著,值得临床应用。
  • 查看更多

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号